Sökning: id:"swepub:oai:DiVA.org:liu-187573" >
Treatment Patterns ...
Treatment Patterns and Clinical Outcomes of Chronic Urticaria : Two-year Follow-up Results from the Scandinavian AWARE Study
-
- Thomsen, Simon F. (författare)
- Univ Copenhagen, Denmark; Univ Copenhagen, Denmark
-
- Pritzier, Ellen C. (författare)
- Stavanger Univ Hosp, Norway
-
- Anderson, Chris (författare)
- Linköpings universitet,Avdelningen för cellbiologi,Medicinska fakulteten,Region Östergötland, Hudkliniken i Östergötland
-
visa fler...
-
- Juvik, Siri (författare)
- Novartis Norge AS, Norway
-
- Baust, Nicolas V. (författare)
- Novartis Norge AS, Norway
-
- Dodge, Rikke (författare)
- Novartis Pharmaceut AS, Denmark
-
- Dahlborn, Anna-Karin (författare)
- Novartis Sweden AB, Sweden
-
- Vestergaard, Christian (författare)
- Aarhus Univ Hosp, Denmark
-
visa färre...
-
(creator_code:org_t)
- 2022-04-07
- 2022
- Engelska.
-
Ingår i: Acta Dermato-Venereologica. - : Society for the Publication of Acta Dermato - Venereologica. - 0001-5555 .- 1651-2057. ; 102
- Relaterad länk:
-
https://liu.diva-por... (primary) (Raw object)
-
visa fler...
-
https://doi.org/10.2...
-
https://urn.kb.se/re...
-
https://doi.org/10.2...
-
visa färre...
Abstract
Ämnesord
Stäng
- The AWARE (A World-wide Antihistamine-Refractory chronic urticaria patient Evaluation) study investigated outcomes in patients with chronic urticaria refractory to H1-antihistamine. The objective of the current study was to analyse the effects of treatment on patients symptoms and quality of life for a period of up to 2 years. Over the 2 years, there was clear improvement in the high rates of disease burden from baseline, as evidenced by lower scores for disease severity scales, better quality of life, and a decreasing rate of medical resource utilization. However, this is the result of treatment adherence to the guidelines in highly specialized Scandinavian urticaria centres, and has its basis in the relatively low treatment intensity and control at enrolment. There is a need for greater adherence to the treatment guidelines and better management of antihistamine-refractory chronic urticaria.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Dermatologi och venereologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Dermatology and Venereal Diseases (hsv//eng)
Nyckelord
- chronic urticaria; quality of life; patient-reported outcomes; omalizumab; AWARE
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas